Previous Article | Next Article 
Journal of Clinical Microbiology, February 1998, p. 587-588, Vol. 36, No. 2
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Fatal Pulmonary Infection with Mycobacterium
celatum in an Apparently Immunocompetent Patient
Irene
Bux-Gewehr,1
Hans P.
Hagen,1
Sabine
Rüsch-Gerdes,2 and
Gerhard E.
Feurle1,*
I. Medizinische Klinik, DRK-Krankenhaus
Neuwied, 56564 Neuwied,1 and
Forschungszentrum Borstel, 23845 Borstel,2 Germany
Received 2 May 1997/Returned for modification 31 May 1997/Accepted 5 November 1997
 |
ABSTRACT |
Mycobacterium celatum is a recently described
mycobacterium isolated from patients who have suppressed cell-mediated
immunity, such as AIDS. We present here, to our knowledge, the first
report of a fatal pulmonary infection caused by M. celatum
in a 73-year-old immunocompetent female patient. The mycobacterium was
identified by a 16S rRNA sequence analysis.
 |
TEXT |
Mycobacterium celatum is
a recently described nontuberculous mycobacterium (3, 18).
These nontuberculous, or atypical, mycobacteria are found widely in
nature. Only a few species are pathogenic in humans. The epidemiology
of these organisms is not well understood, but person-to-person
transmission has never been demonstrated. Most infections occur in
patients with suppressed cell-mediated immunity, such as AIDS (6,
9, 13, 17). Immunocompetent patients are rarely infected. Single
cases of pulmonary infection or lymphadenitis caused by
Mycobacterium scrofulaceum, Mycobacterium avium
complex, or Mycobacterium kansasii have been observed
(1). One child with lymphadenitis caused by M. celatum has been reported (8). To our knowledge, a
pulmonary infection by M. celatum is an immunocompetent
patient has not been described.
Case report.
A 73-year-old female Caucasian patient (163 cm,
61 kg) developed a nonproductive cough. Her medical and family
histories were unremarkable, apart from diabetes mellitus type 2 diagnosed in 1985 and treated with glyburide (glibenclamide) (HbA1,
10.5%). Physical examination revealed no pathological findings except moist rales in the upper left lung.
A chest X ray (Fig. 1) and the presence
of acid-fast bacteria in the sputum indicated a mycobacterial pulmonary
infection. As the strongly positive tine test suggested
immunocompetence, infection with Mycobacterium tuberculosis
was assumed and treatment was started with isoniazid, pyrazinamide,
ethambutol, and rifampin. In the following 4 weeks, the general
condition of the patient deteriorated. Her temperature increased to
39°C, and respiratory insufficiency developed. When atypical
mycobacteria with resistance to isoniazid and rifampin were isolated,
ciprofloxacin and clarithromycin were added to pyrazinamide,
ethambutol, theophylline, and inhalation of terbutaline and
fluticasone. The patient felt better for 3 weeks. Thereafter, her
condition worsened, and a chest X ray showed an extended infiltrate
including the left lower pulmonary lobe (Fig.
2). The patient died 10 weeks after
admission. M. celatum was identified by a 16S rRNA sequence
analysis only after her death.

View larger version (151K):
[in this window]
[in a new window]
|
FIG. 2.
X ray taken 10 weeks after that in Fig. 1; the
infiltrate had progressed to include the left lower pulmonary lobe.
|
|
Laboratory analysis revealed acid-fast bacteria in the gastric juice
and the sputum. The erythrocyte sedimentation rate was 120/120 mm/h,
hemoglobin was 131 g/liter, thrombocytes were 438/nl, and leukocytes
were 8.1/nl (neutrophils, 83%; monocytes, 8%; eosinophils, 1%;
lymphocytes, 8%). The lymphocyte subpopulations were T4, 36.5% (237/µl), and T8, 14.7% (95/µl); the T4/T8 ratio was 2.5. Analysis of the blood gases showed a pH of 7.53, a partial CO2
pressure of 5.25 kPa, a partial O2 pressure of 7.5 kPa, and
oxygen saturation of 92%. The tine test was strongly positive. Serum
protein electrophoresis and clotting tests, serum aminotransferases and
electrolytes, and the creatinine clearance rate were within normal
limits, and antibodies against human immunodeficiency virus types 1 and
2 were not present.
The organism was initially cultured from sputum with liquid medium
(BACTEC; Becton Dickinson) over 3 weeks. Primary culture
on solid
medium (Löwenstein-Jensen) was unsuccessful. The acid-fast
organism from the gastric juice was not cultured. The isolated
mycobacterium grew at 31 to 45°C; it was Tween 80 hydrolysis
negative,
nitrate reductase negative, arylsulfatase negative, and
nicotinic
acid and pyrazinamidase positive. DNA probes (Accuprobe;
Gen-Probe
Inc., San Diego, Calif.) specific for
M. tuberculosis complex
were positive after 5 min but negative after
10 min of hybridization.
The gene fragment of the 16S rRNA was
sequenced as described previously
(
3) and identified as
belonging to
M. celatum. Susceptibility
testing by the
proportion method with Löwenstein-Jensen medium
revealed
resistance to isoniazid, rifampin, and pyrazinamide but
sensitivity to
ethambutol. These results were confirmed by a radiometric
method
(BACTEC 460TB).
Discussion.
To our knowledge, this is the first report of a
pulmonary infection by M. celatum in a patient with
apparently normal cellular immunity. This species was initially
recognized by biochemical reactions similar to those of M. avium but presented a mycolic acid pattern that was like that of
Mycobacterium xenopi (4, 15). Also, the DNA probe
used for culture confirmation may give misleading results, because the
M. tuberculosis DNA probe shows cross-reactivity in cases of
M. celatum (type I) infection, causing false-positive
hybridization signals (5 min hybridization time) (2, 16).
Identification of M. celatum has been made possible by
restriction fragment length polymorphism analysis of the amplified sequence of the Hsp65 gene, multilocus enzyme electrophoresis, and 16S
rRNA sequence analysis (3).
M. celatum cannot be identified by biochemical
characteristics. At present the most practical way to distinguish
M. celatum from other mycobacteria seems to be a positive
DNA hybridization
signal for
M. tuberculosis complex at 5 min but negative hybridization
at 10 min with the Accuprobe test.
Our patient did not have AIDS, and the strongly positive intracutaneous
reaction to tuberculin indicated cellular immunocompetence.
The total
T4 helper cell number was low due to lymphopenia. The
T4/T8 ratio was
in the normal range. Lymphocytopenia in the circulating
blood is a
characteristic feature of active tuberculosis (
10,
12); it
may be caused by local recruitment of CD4 T lymphocytes
to the sites of
infection, such as granulomas and pleural and
ascitic exudates, where
lymphocytes are abundant (
11,
14).
A normal peripheral
lymphocyte count is rapidly restored when
treatment is successful
(
12). In AIDS, in contrast, total CD4
T lymphocyte numbers
are depleted due to human immunodeficiency
virus-induced lymphocyte
destruction and secondary to impaired
lymphocyte production due to loss
of the normal thymic-lymphoid
architecture (
7).
The patient's mild diabetes mellitus is unlikely to have contributed
much to her susceptibility to infection. This means that
pulmonary
infection with
M. celatum occurred in an apparently
immunocompetent host. The delay of 4 weeks until the correct diagnosis
of a nontuberculous mycobacteriosis was made and treatment with
antimicrobials to which the offending organism was resistant may
have
contributed to the fatal outcome.
This report of a pulmonary infection with
M. celatum
indicates that not only the known nontuberculous mycobacteria,
M. kansasii,
M. avium, and
M. scrofulaceum, can
cause infections in immunocompetent
humans (
1). An exact and
rapid diagnosis with direct amplified
tests, as described for
M. tuberculosis (
5), and advances in
diagnostic technology
may be crucial for successful treatment
of a nontuberculous
mycobacterial infection.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: DRK-Krankenhaus
Neuwied, Marktstrasse 74, 56564 Neuwied, Germany. Phone:
49-2631-981401. Fax: 49-2631-981040. E-mail:
bux-gewehr{at}t-online.de.
 |
REFERENCES |
| 1.
|
Brodt, H. R.
1992.
Aktuelle Therapie atypischer Mycobacteriosen.
Immun. Infekt.
20:39-45[Medline].
|
| 2.
|
Butler, W. R.,
S. P. O'Connor,
M. A. Yakrus, and W. M. Gross.
1994.
Cross-reactivity of genetic probe for detection of Mycobacterium tuberculosis with newly described species Mycobacterium celatum.
J. Clin. Microbiol.
32:536-538[Abstract/Free Full Text].
|
| 3.
|
Butler, W. R.,
S. P. O'Connor,
M. A. Yakrus,
R. W. Smithwick,
B. B. Plikaytis,
C. W. Moss,
M. M. Floyd,
C. L. Woodley,
J. O. Kilburn,
F. S. Vadney, and W. M. Gross.
1993.
Mycobacterium celatum sp. nov.
Int. J. Syst. Bacteriol.
43:539-548[Abstract/Free Full Text].
|
| 4.
|
Butler, W. R.,
L. Thibert, and J. O. Kilburn.
1992.
Identification of Mycobacterium avium complex strains and some similar species by high-performance liquid chromatography.
J. Clin. Microbiol.
30:2698-2704[Abstract/Free Full Text].
|
| 5.
|
Canzaro, A.
1996.
Value of direct amplified test for diagnosis of tuberculosis.
Lancet
347:1500-1501[Medline].
|
| 6.
|
Emler, S.,
P. Praplan,
P. Robner,
R. Auckenthaler, and B. Hirschel.
1996.
Disseminierte Infektion mit Mycobacterium celatum.
Schweiz. Med. Wochenschr.
126:1062-1065[Medline].
|
| 7.
|
Finkel, T. H., and N. K. Banda.
1994.
Indirect mechanism of HIV pathogenesis: how does HIV kill T cells?
Curr. Opin. Immunol.
6:605-615[Medline].
|
| 8.
|
Haase, G.,
H. Skopnik,
S. Bätge, and E. C. Böttger.
1994.
Cervical lymphadenitis caused by Mycobacterium celatum.
Lancet
344:1020-1021[Medline].
|
| 9.
|
Horsburg, C. R.
1991.
Mycobacterium avium complex in the acquired immune deficiency syndrome.
N. Engl. J. Med.
324:1332-1338[Medline].
|
| 10.
|
Maartens, G.,
P. A. Willcox, and S. R. Benatar.
1990.
Miliary tuberculosis: rapid diagnosis, hematologic abnormalities, and outcome in 109 treated adults.
Am. J. Med.
89:291-296[Medline].
|
| 11.
|
Montes Santiago, J.,
F. Gambon Deza,
M. Pacheco Carracedo, and T. Cerda Mota.
1996.
Cellular immune response in tuberculosis: analysis of T-lymphocytes and their subsets, B-lymphocytes and natural cytotoxic cells in different tuberculosis states and body fluids.
Rev. Clin. Esp.
196:223-227[Medline].
|
| 12.
|
Onwubalili, J. K.
1990.
Untreated tuberculosis may be associated with lymphopenia, not lymphocytosis.
Afr. J. Med. Med. Sci.
19:181-183[Medline].
|
| 13.
|
Piersimoni, C.,
E. Tortoli, and G. De Sio.
1994.
Disseminated infection due to Mycobacterium celatum in patient with AIDS.
Lancet
344:332[Medline].
|
| 14.
|
Rook, G. A. W.,
J. W. Carswell, and J. L. Stanford.
1976.
Preliminary evidence for the trapping of antigen-specific lymphocytes in the lymphoid tissue of `anergic' tuberculosis.
Clin. Exp. Immunol.
26:129-132[Medline].
|
| 15.
|
Saubolle, M. A.,
G. D. Roberts,
N. L. Goodman,
T. Davis, and V. Jonas.
1993.
Isolates of nontuberculous mycobacteria (NTM) identified as members of tuberculosis (MTB) complex by commercial genetic probes, abstr. U93, p. 185.
In
Abstracts of the 93rd General Meeting of the American Society for Microbiology 1993.
|
| 16.
|
Stockman, L.,
B. Springer,
E. C. Böttger, and G. D. Roberts.
1993.
Mycobacterium tuberculosis nucleic acid probes for rapid diagnosis.
Lancet
341:1486[Medline].
|
| 17.
|
Tortoli, E.,
C. Piersimoni,
D. Bacosi,
A. Bartoloni,
F. Betti,
L. Bono,
C. Burrini,
G. De Sio,
C. Lacchini,
A. Mantella,
P. G. Orsi,
V. Penati,
M. T. Simonetti, and E. C. Böttger.
1995.
Isolation of the newly described species Mycobacterium celatum from AIDS Patients.
J. Clin. Microbiol.
33:137-140[Abstract].
|
| 18.
|
Yakrus, M.,
W. Butler,
J. Kilburn,
B. Plikaytis,
C. Moss,
V. Silcox,
M. Floyd,
F. Vadney, and W. Gross.
1992.
Characterization of a new drug-resistant mycobacterium species associated with pulmonary disease in AIDS patients, abstr. U-24, p. 169.
In
Abstracts of the 92nd General Meeting of the American Society for Microbiology 1992.
|
Journal of Clinical Microbiology, February 1998, p. 587-588, Vol. 36, No. 2
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Wada, H., Yamamoto, M., Okazaki, M., Watanabe, T., Goto, H.
(2009). Isolation of Mycobacterium kyorinense in a Patient With Respiratory Failure. ANN INTERN MED
150: 568-570
[Full Text]
-
Tortoli, E.
(2003). Impact of Genotypic Studies on Mycobacterial Taxonomy: the New Mycobacteria of the 1990s. Clin. Microbiol. Rev.
16: 319-354
[Abstract]
[Full Text]
-
Lau, S K P, Woo, P C Y, Teng, J L L, Leung, K W, Yuen, K Y
(2002). Identification by 16S ribosomal RNA gene sequencing of Arcobacter butzleri bacteraemia in a patient with acute gangrenous appendicitis. Mol. Pathol.
55: 182-185
[Abstract]
[Full Text]
-
Turenne, C. Y., Tschetter, L., Wolfe, J., Kabani, A.
(2001). Necessity of Quality-Controlled 16S rRNA Gene Sequence Databases: Identifying Nontuberculous Mycobacterium Species. J. Clin. Microbiol.
39: 3637-3648
[Abstract]
[Full Text]
-
Zheng, X., Pang, M., Engler, H. D., Tanaka, S., Reppun, T.
(2001). Rapid Detection of Mycobacterium tuberculosis in Contaminated BACTEC 12B Broth Cultures by Testing with Amplified Mycobacterium Tuberculosis Direct Test. J. Clin. Microbiol.
39: 3718-3720
[Abstract]
[Full Text]
-
Woo, P C Y, Leung, A S P, Leung, K W, Yuen, K Y
(2001). Identification of slide coagulase positive, tube coagulase negative Staphylococcus aureus by 16S ribosomal RNA gene sequencing. Mol. Pathol.
54: 244-247
[Abstract]
[Full Text]
-
Valheim, M., Djonne, B., Heiene, R., Caugant, D. A.
(2001). Disseminated Mycobacterium celatum (Type 3) Infection in a Domestic Ferret (Mustela putorius furo). Vet Pathol
38: 460-463
[Abstract]
[Full Text]
-
Tjhie, J. H. T., van Belle, A. F., Dessens-Kroon, M., van Soolingen, D.
(2001). Misidentification and Diagnostic Delay Caused by a False-Positive Amplified Mycobacterium tuberculosis Direct Test in an Immunocompetent Patient with a Mycobacterium celatum Infection. J. Clin. Microbiol.
39: 2311-2312
[Abstract]
[Full Text]
-
Kellogg, J. A., Bankert, D. A., Withers, G. S., Sweimler, W., Kiehn, T. E., Pfyffer, G. E.
(2001). Application of the Sherlock Mycobacteria Identification System Using High-Performance Liquid Chromatography in a Clinical Laboratory. J. Clin. Microbiol.
39: 964-970
[Abstract]
[Full Text]
-
Fattorini, L., Baldassarri, L., Li, Y.-J., Ammendolia, M. G., Fan, Y., Recchia, S., Iona, E., Orefici, G.
(2000). Virulence and drug susceptibility of Mycobacterium celatum. Microbiology
146: 2733-2742
[Abstract]
[Full Text]
-
Woo, P. C. Y., Tsoi, H.-W., Leung, K.-W., Lum, P. N. L., Leung, A. S. P., Ma, C.-H., Kam, K.-M., Yuen, K.-Y.
(2000). Identification of Mycobacterium neoaurum Isolated from a Neutropenic Patient with Catheter-Related Bacteremia by 16S rRNA Sequencing. J. Clin. Microbiol.
38: 3515-3517
[Abstract]
[Full Text]
-
Woo, P C Y, Leung, P K L, Leung, K W, Yuen, K Y
(2000). Identification by 16S ribosomal RNA gene sequencing of an Enterobacteriaceae species from a bone marrow transplant recipient. Mol. Pathol.
53: 211-215
[Abstract]
[Full Text]
-
Somoskövi, A., Hotaling, J. E., Fitzgerald, M., Jonas, V., Stasik, D., Parsons, L. M., Salfinger, M.
(2000). False-Positive Results for Mycobacterium celatum with the AccuProbe Mycobacterium tuberculosis Complex Assay. J. Clin. Microbiol.
38: 2743-2745
[Abstract]
[Full Text]
-
Jorgensen, J. H., Salinas, J. R., Paxson, R., Magnon, K., Patterson, J. E., Patterson, T. F.
(1999). False-Positive Gen-Probe Direct Mycobacterium tuberculosis Amplification Test Results for Patients with Pulmonary M. kansasii and M. avium Infections. J. Clin. Microbiol.
37: 175-178
[Abstract]
[Full Text]